In the nasal treatment experiment of AD transgenic mice, Mn3O4 nanozymes promoted the polarization of microglia to M2 phenotype after 4 weeks of treatment, while fAβ pathology and cognitive deficits of mice were alleviated after 8 weeks of treatment. The gene discussed is FANCB; the disease is Alzheimer disease.